Maternal Death

4

Review clinical trials related to Maternal Death. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Assessing the Maternal Outcome Monitoring Systems

Pregnancy-related death is a growing public health issues, which are of particular concern to minority groups, including African-Americans and Spanish-speaking Latinas. Our proposal aims to improve a patient's ability to detect warning signs of pregnancy related death and seek medical care.

Participants needed: 80
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Columbia UniversityUpdated: Jun 1, 2026Locations: 2
Eligibility criteria

Greater than 28 weeks pregnant [+4]

Severe cognitive impairment [+2]

Status: Recruiting

The Effects of Medicaid Policy Interventions on Racial Equity in Severe Maternal Morbidity

The goal of this study is to learn about the effects of structural inventions, such as equity-focused Medicaid polices, on severe maternal morbidity (SMM) and mortality and maternal health. The main questions it aims to answer are: 1. What is the effect of Medicaid healthcare quality interventions on SMM? 2. What is the effect of Medicaid healthcare quality interventions + doula care? 3. What are Medicaid beneficiaries' experiences in receiving services and the potential impact of integration of doula services and equity practices? Participants will be asked to describe experiences as a result of structural interventions and focused Medicaid policies.

Participants needed: 10,000,000
Trial details
Biological sex: AllType: InterventionalSponsor: University of PittsburghUpdated: Jul 22, 2025Locations: 1
Eligibility criteria

Pregnant and postpartum Medicaid beneficiaries across the US [+3]

Status: Recruiting

Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach

Overall Objective To introduce PartoMa approach (locally agreed and achievable intrapartum guidelines and a continual in-house training program) to Ethiopian context through continuous fetal heart rate (FHR) monitoring using MOYO device and co-creation of context specific intrapartum care guideline for improving decision making in intrapartum care in Eastern Ethiopia. Interventions 1. Locally agreed and achievable intrapartum guidelines 2. Low dose high frequency trainings (LDHF) 3. Partograph Overall Design A quasi-experimental pre-post study (PartoMa study) Setting Department of Obstetrics and Gynaecology Haramaya Hospital and Hiwot Fana University Hospital, Ethiopia. Population Laboring women delivering at the study site from February 2023 to March 2025 and their offspring, as well as health providers. Women and their offspring will be enrolled at/after onset of labour and followed until discharge. Endpoints The primary endpoint is perinatal mortality. For further description and secondary outcomes, please see below. Study Time Data collection from June 2023 to May 2025. Specific Objectives i. To assess FHR monitoring practice and use of obstetric guideline for decision making in Hiwot Fana University Hospital ii. To improve feto-maternal outcome through applying PartoMa approach in Hiwot Fana University Hospital. iii. To determine the feasibility, acceptability and sustainability of low-dose high frequency trainings and PartoMa seminars in Hiwot Fana University Hospital. iv. To document changes in pregnancy outcomes after the introduction of PartoMa approaches-seminars, low dose high frequency trainings, continuous FHR monitoring and tailored interventions-in Hiwot Fana University Hospital. Setting PartoMa Ethiopia will be implemented at Haramaya General Hospital and Hiwot Fana Comprehensive Specialized University Hospital, which are both busy maternity units in Eastern Ethiopia. Both are government hospitals with an annual delivery number of around 5,000.

Participants needed: 500
Trial details
Age: 18-50Biological sex: FemaleType: InterventionalSponsor: Haramaya UnversityUpdated: Feb 22, 2024Locations: 2
Eligibility criteria

All women in labour delivering at the study site and their outcome, July - Septe... [+1]

NA

Status: Recruiting

Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage

This will be the first, definitive, randomized control trial (N=424) to test the hypothesis that the Jada® System is effective, safe and cost-effective in treating PPH, compared to standard care.

Participants needed: 424
Trial details
Age: 18-44Biological sex: FemaleType: InterventionalSponsor: Women and Infants Hospital of Rhode IslandUpdated: Dec 21, 2023Locations: 2
Eligibility criteria

18 years or older [+5]

Patient unwilling or unable to provide informed consent [+6]